Prefilled Syringes Market

Analysis from GMI Research finds that the Prefilled Syringes Market earned revenues of USD 6.4 billion in 2022 and forecast to touch USD 13.8 billion in 2030 will grow at a CAGR of 10.1% from 2023-2030.

To have an edge over the competition by knowing the market dynamics and current trends of “Prefilled Syringes Market”, request for Sample Report here

Market Dynamic

Key Drivers and Emerging Trends

The major factors fueling the prefilled syringes market size includes rising demand for advanced, effective, and user-friendly drug delivery devices, strategic government regulations, and growing emphasis of healthcare professionals to minimize hospital fallacies. Ongoing technological developments in injectable delivery solutions and the growing incidence of chronic diseases, such as diabetes will further expand the market growth over the upcoming years. As per the International Diabetes Federation (IDF), nearly 537 million people between the age of 20 years and 79 years had diabetes in 2021.

As per the prefilled syringes market analysis, the increasing adoption of prefilled syringes in various applications of medical sectors, which include vaccines, therapeutic proteins, and blood stimulants, owing to their remarkable advantages which include reduction in dosing errors and easy usage, has propelled the market growth. As per the Centers for Disease Control and Prevention (CDC), the use of safety measures like prefilled syringes in hospitals can decrease sharps-related injuries by 60-88%.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Type – Segment Analysis

Based on the type, plastic based segment is expected to grow at a higher CAGR in the global prefilled syringes market. Inertness and clarity offered by the plastic based products is major factor behind the growth of the market. Plastic based syringes maintain the property of stored drug dosage while increasing the level of safety. Additionally, plastic refilled syringes reduce the cost of the dose, which is further anticipated to fuel the demand.

Application – Segment Analysis

Based on the application, diabetes segment is expected to dominate the global prefilled syringes market over the forecast period. Rise in prevalence of diabetes and the need for safer and effective insulin delivery devices are the factors that are boosting the segmental growth. According to WHO, it has been witnessed that almost half of all deaths attributable to high blood glucose occur before the age of 70.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

Regional – Segment Analysis

Based on the region, Europe is expected to dominate the global prefilled syringes market, over the forecast period. This is due to the strong presence of key players in the market, such as J&J, BD, Gerresheimer AG, Owen Mumford Ltd. etc., that have helped in the expansion of the market size in the region. Enhanced rate of chronic disease is another factor contributing to the growth of the region. According to “European Chronic Disease Alliance” one third of the European population, and 23.5% of the working age population in the EU lives with chronic disease. Globally, Europe has the highest burden of chronic diseases, which are responsible for 86% of all deaths and is a major cause of morbidity and disability, which has fuelled the growth of the region.

Top Market Players

Various notable players operating in the market, include, BD, J&J, Gerresheimer AG, Owen Mumford Ltd. etc., Medtronic, Gerresheimer AG, SCHOTT, Stevanato Group, HONJO-NISHI KITA-KU OSAKA, Haselmeier, among others. 

Key Developments:

• • In 2020, J&J and Catalent have signed an agreement for the launch of prefilled syringes in U.S., this has helped the company in expanding the focused product portfolio.
  •  In 2022, Owen Mumford received an approval for its UniSafe 1mL safety device for pre-filled syringes in Asia and Europe by regulatory bodies. The product is now available in the market as a combination product with a drug to treat rheumatoid arthritis.
  • In 2021, Aurobindo Pharma Limited received approval to produce and sale Naloxone HCl Injection Prefilled Syringe 2 mg/2 mL from the United States Food and Drug Administration (USFDA).

Segments Covered in the Report:

The global prefilled syringes market has been segmented on the basis of type, application, chamber and regions. Based on type, the market is segmented into glass and plastic. Based on application the market is segmented into diabetes, cancer, arthritis, anaphylaxis, and ophthalmology. Based on chamber the market is segmented into single and dual. 

For detailed scope of the “Prefilled Syringes Market” report request a Sample Copy of the report

Key questions answered in this research report:

• • At what pace is global prefilled syringes market growing? What will be the growth trend in the future?
  • What are the key drivers and restraints in prefilled syringes market? What will be the impact of drivers and restraints in the future?
  • What are the regional revenues and forecast breakdowns? Which are the major regional revenue pockets for growth in the global prefilled syringes market?
  • Which type generated maximum revenues in 2021 and identify the most promising type during the forecast period?
  • What are the various Chamber areas of global prefilled syringes market and how they are poised to grow?
  • What companies are the major participants in this market and their business strategies, how does the competitive landscape look like?

Market Segmentation

Global Prefilled Syringes Market by Type

• • Glass Based
    • Oil Siliconised Syringes
    • Baked on Silence Syringes
  • Plastic Based

Global Prefilled Syringes Market by Chamber

• • Single
  • Dual

Global Prefilled Syringes Market by Application

• • Diabetes
  • Cancer
  • Arthritis
  • Anaphylaxis
  • Ophthalmology

Global Prefilled Syringes Market by Region

• • North America Prefilled Syringes Market (Option 1: As a part of the free 25% customization)

    • By Type
    • By Chamber
    • By Application
    • US Market All-Up
    • Canada Market All-Up

  • Europe Prefilled Syringes Market (Option 2: As a part of the free 25% customization)

    • By Type
    • By Chamber
    • By Application
    • UK Market All-Up
    • Germany Market All-Up
    • France Market All-Up
    • Spain Market All-Up
    • Rest of Europe Market All-Up

  • Asia-Pacific Prefilled Syringes Market (Option 3: As a part of the free 25% customization)

    • By Type
    • By Chamber
    • By Application
    • China Market All-Up
    • India Market All-Up
    • Japan Market All-Up
    • Rest of APAC Market All-Up

  • RoW Prefilled Syringes Market (Option 4: As a part of the free 25% customization)

    • By Type
    • By Chamber
    • By Application
    • Brazil Market All-Up
    • South Africa Market All-Up
    • Saudi Arabia Market All-Up
    • UAE Market All-Up
    • Rest of world (remaining countries of the LAMEA region) Market All-Up

Major Players Operating in the Prefilled Syringes (Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)

• • BD
  • J&J
  • Gerresheimer AG
  • Owen Mumford Ltd.
  • Medtronic
  • Gerresheimer AG
  • SCHOTT
  • Stevanato Group
  • HONJO-NISHI KITA-KU OSAKA
  • Haselmeier